Recent Advances in the Treatment of Multiple Myeloma: Highlights from the ASH 2021 Meeting

A panel of experts provides a discussion on treatments for newly diagnosed transplant eligible, transplant ineligible, and relapsed multiple myeloma, and how recent clinical trial data presented at ASH 2021 can be applied to clinical practice.